Tag: IP shipment return

Proper Documentation for Returned Investigational Products in Clinical Trials

July 19, 2025

Proper Documentation for Returned Investigational Products in Clinical Trials How to Document Returned Investigational Products in Clinical Trials Proper documentation of returned Investigational Products (IP) is a regulatory requirement that ensures accountability, safety, and traceability in clinical trials. Whether due to expiration, damage, overstock, or completion of subject treatment, returned IPs must be logged and…

Clinical Trial Supply and Logistics, Return and Destruction of Supplies

Timing and Triggers for Investigational Product Returns in Clinical Trials

July 17, 2025

digi

Timing and Triggers for Investigational Product Returns in Clinical Trials When and Why to Return Investigational Products in Clinical Trials Returning unused or partially used Investigational Products (IPs) from trial sites is a key component of pharmaceutical logistics and regulatory compliance. Properly timed returns help prevent wastage, mitigate compliance risks, and ensure accurate reconciliation at…

Clinical Trial Supply and Logistics, Return and Destruction of Supplies